TALi Digital (ASX:TD1) - Managing Director, Glenn Smith
Managing Director, Glenn Smith
Sourced: TALi Digital
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Digital health business, TALi Digital (TD1) expects to raise $3.22 million from a placement and entitlement offer to support the commercialisation and development of its products
  • The placement will issue 139.8 million new shares at 1.1 cents each to raise $1.54 million
  • This represents a 42.1 per cent discount to the last closing price and a 53.3 per cent discount to the 15 day volume weighted average price
  • The entitlement offer will offer shares at the same price and aims to raise a further $1.68 million
  • Shares have plummeted 31.6 per cent to 1.3 cents each

Digital health business, TALi Digital (TD1) expects to raise $3.22 million from a placement and entitlement offer to support the commercialisation and development of its products.

The funds will assist the company’s first-generation products with commercialisation.

They will also be utilised to clinically develop a second-generation offering and finance continued global partnership discussions.

A total of $1.54 million was raised in the placement from institutional and sophisticated investors.

The placement will see 139.8 million new shares issued at a price of 1.1 cents each.

This represents a massive 42.1 per cent discount to the last closing price and a 53.3 per cent discount to the 15-day volume-weighted average price.

Shares under the entitlement offer will be offered at the same price with shareholders able to subscribe for one new share for every seven held.

This is expected to raise $1.68 million.

TALi directors will participate in both the placement and entitlement offer, subject to shareholder approval.

“2022 is shaping up to be a transformative year for TALi,” Chairperson Sue MacLeman said.

“With the Akili agreement in place we have a strong and capable U.S. partner with whom
to bring our products to the largest healthcare market in the world.”

Taylor Collison has informed the company that it has obtained binding sub-underwriting commitments in the amount of $1.68 million, which is the amount planned to be raised under the entitlement offer. Tali intends to enter into an underwriting agreement with Taylor Collison to fully underwrite the entitlement offer.

Shares have plummeted 31.6 per cent to 1.3 cents each at 11:40 am AEDT.

TD1 by the numbers
More From The Market Online

Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy

The big thematics and headlines that drove the ASX this week, plus, the headlines I think…
The Market Online Video

Market Close: ASX signs off on a sigh with all sectors red-lining

The ASX200 finished 1.3 per cent down with every sector in the red and Industrials and Real Estate brittle and bruised as bot…
The Market Online Video

Market Update: ASX on red alert with all sectors below the surface

The ASX200 is trading down around 1.1% with all eleven sectors in the red. Real-estate has…

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.